Instead, local use of dipeptidyl peptidase-4 (DPP4) inhibitors to block CXCL12-inactivating enzymes may be hypothesized to locally increase the ligand levels and further validate this role of this chemokine in impairing tumor progression toward metastasis. The gene discussed is DPP4; the disease is neoplasm.